D. D. Wagner, Cell biology of von Willebrand factor, Annu Rev Cell Biol, vol.6, pp.217-263, 1990.

Y. Zhou, E. T. Eng, J. Zhu, C. Lu, T. Walz et al., Sequence and structure relationships within von Willebrand factor, Blood. 12 juill, vol.120, issue.2, pp.449-58, 2012.

M. A. Brehm, Von Willebrand factor processing, Hämostaseologie, vol.37, issue.01, pp.59-72, 2017.

A. Katsumi, E. A. Tuley, I. Bodó, and J. E. Sadler, Localization of Disulfide Bonds in the Cystine Knot Domain of Human von Willebrand Factor, J Biol Chem. 18 août, vol.275, issue.33, pp.25585-94, 2000.

D. D. Wagner, S. O. Lawrence, B. M. Ohlsson-wilhelm, P. J. Fay, and V. J. Marder, Topology and order of formation of interchain disulfide bonds in von Willebrand factor, Blood. 1 janv, vol.69, issue.1, pp.27-32, 1987.

A. R. Purvis and J. E. Sadler, A Covalent Oxidoreductase Intermediate in Propeptidedependent von Willebrand Factor Multimerization, J Biol Chem, vol.279, issue.48, pp.49982-49990, 2004.

T. A. Springer, Biology and Physics of von Willebrand Factor Concatamers, J Thromb Haemost JTH. juill, vol.9, issue.1, pp.130-173, 2011.

Y. Zhou, E. T. Eng, N. Nishida, C. Lu, T. Walz et al., A pH-regulated dimeric bouquet in the structure of von Willebrand factor, EMBO J. 19 août, vol.30, pp.4098-111, 2011.

P. J. Lenting, C. Casari, O. D. Christophe, and C. V. Denis, von Willebrand factor: the old, the new and the unknown, J Thromb Haemost. 1 déc, vol.10, issue.12, pp.2428-2465, 2012.

T. A. Springer and . Von-willebrand-factor, Jedi knight of the bloodstream, Blood, vol.124, issue.9, pp.1412-1437, 2014.

Y. Zhou, E. T. Eng, J. Zhu, C. Lu, T. Walz et al., Sequence and structure relationships within von Willebrand factor, Blood. 12 juill, vol.120, issue.2, pp.449-58, 2012.

J. E. Sadler, von Willebrand factor assembly and secretion, J Thromb Haemost, vol.7, issue.s1, pp.24-31

L. A. Sporn, V. J. Marder, and D. D. Wagner, Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells, J Cell Biol. avr, vol.108, issue.4, pp.1283-1292, 1989.

M. Galbusera, C. Zoja, R. Donadelli, S. Paris, M. Morigi et al., Fluid Shear Stress Modulates von Willebrand Factor Release From Human Vascular Endothelium, Blood, vol.90, issue.4, pp.1558-64, 1997.

G. Rastegarlari, J. N. Pegon, C. Casari, S. Odouard, A. Navarrete et al.,

, Macrophage LRP1 contributes to the clearance of von Willebrand factor, Blood. 1 mars, vol.119, issue.9, pp.2126-2160, 2012.

C. Casari, P. J. Lenting, N. Wohner, O. D. Christophe, and C. V. Denis, Clearance of von Willebrand factor, J Thromb Haemost, vol.11, issue.s1, pp.202-213

M. Furlan, Von Willebrand factor: molecular size and functional activity, Ann Hematol. juin, vol.72, issue.6, pp.341-349, 1996.

Z. M. Ruggeri and W. J. Von-willebrand-factor, FASEB J Off Publ Fed Am Soc Exp Biol. 1 févr, vol.7, issue.2, pp.308-324, 1993.

K. Titani, S. Kumar, K. Takio, L. H. Ericsson, R. D. Wade et al., Amino acid sequence of human von Willebrand factor, Biochemistry. 3 juin, vol.25, issue.11, pp.3171-84, 1986.

T. Marti, S. J. Rösselet, K. Titani, and K. A. Walsh, Identification of disulfide-bridged substructures within human von Willebrand factor, Biochemistry. 15 déc, vol.26, issue.25, pp.8099-109, 1987.

C. A. Siedlecki, B. J. Lestini, K. K. Kottke-marchant, S. J. Eppell, D. L. Wilson et al., Shear-dependent changes in the three-dimensional structure of human von Willebrand factor, Blood, vol.88, issue.8, pp.2939-50, 1996.

S. P. Jackson, The growing complexity of platelet aggregation, Blood. 15 juin, vol.109, issue.12, pp.5087-95, 2007.

D. J. Ahr, F. R. Rickles, L. W. Hoyer, D. S. O'leary, and M. E. Conrad, von Willebrand's disease and hemorrhagic telangiectasia: association of two complex disorders of hemostasis resulting in life-threatening hemorrhage, Am J Med. mars, vol.62, issue.3, pp.452-460, 1977.

E. Fressinaud and D. Meyer, International survey of patients with von Willebrand disease and angiodysplasia, Thromb Haemost. 1 sept, vol.70, issue.3, p.546, 1993.

J. K. Koscielny, R. Latza, S. Mürsdorf, C. Mrowietz, H. Kiesewetter et al., Capillary microscopic and rheological dimensions for the diagnosis of von Willebrand disease in comparison to other haemorrhagic diatheses, Thromb Haemost. déc, vol.84, issue.6, pp.981-989, 2000.

R. D. Starke, F. Ferraro, K. E. Paschalaki, N. H. Dryden, T. Mckinnon et al., Endothelial von Willebrand factor regulates angiogenesis, Blood. 20 janv, vol.117, issue.3, pp.1071-80, 2011.

R. D. Starke, K. E. Paschalaki, C. Dyer, K. J. Harrison-lavoie, J. A. Cutler et al., Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells, Blood. 4 avr, vol.121, issue.14, pp.2773-84, 2013.

A. M. Randi, M. A. Laffan, and R. D. Starke, Von Willebrand Factor, Angiodysplasia and Angiogenesis, Mediterr J Hematol Infect Dis, vol.5, issue.2, 2013.

A. M. Randi, K. E. Smith, and G. Castaman, von Willebrand factor regulation of blood vessel formation, Blood. 12 juill, vol.132, issue.2, pp.132-172, 2018.

M. H. Kroll and J. D. Hellums, Platelets and Shear Stress, p.18

G. G. Levy, W. C. Nichols, E. C. Lian, T. Foroud, J. N. Mcclintick et al., Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature. oct, vol.413, issue.6855, pp.488-94, 2001.

M. Uemura, K. Tatsumi, M. Matsumoto, M. Fujimoto, T. Matsuyama et al., Localization of ADAMTS13 to the stellate cells of human liver, Blood. 1 août, vol.106, issue.3, pp.922-926, 2005.

N. Turner, L. Nolasco, Z. Tao, J. Dong, and J. Moake, Human endothelial cells synthesize and release ADAMTS-13, J Thromb Haemost. 1 juin, vol.4, issue.6, pp.1396-404, 2006.

H. M. Tsai, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood. 15 mai, vol.87, issue.10, pp.4235-4279, 1996.

M. Furlan, R. Robles, and B. Lämmle, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood. 15 mai, vol.87, issue.10, pp.4223-4257, 1996.

X. Zhang, K. Halvorsen, C. Zhang, W. P. Wong, and T. A. Springer, Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor, Science, vol.324, issue.5932, pp.1330-1334, 2009.

W. Gao, P. J. Anderson, E. M. Majerus, E. A. Tuley, and J. E. Sadler, Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease, Proc Natl Acad Sci U S A. 12 déc, vol.103, issue.50, pp.19099-104, 2006.

H. Tsai, I. I. Sussman, and R. L. Nagel, Shear stress enhances the proteolysis of von Willebrand factor in normal plasma, Blood, vol.83, issue.8, pp.2171-2179, 1994.

J. E. Sadler, For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, Thromb Haemost. avr, vol.71, issue.4, pp.520-525, 1994.

G. Castaman, A. B. Federici, A. Tosetto, S. L. Marca, F. Stufano et al., Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients, J Thromb Haemost. 1 avr, vol.10, issue.4, pp.632-640, 2012.

A. Veyradier, C. Jenkins, E. Fressinaud, and D. Meyer, Acquired von Willebrand Syndrome: from Pathophysiology to Management, Thromb Haemost, vol.84, issue.2, pp.175-82, 2000.

J. V. Simone, J. A. Cornet, and C. F. Abildgaard, Acquired von Willebrand's syndrome in systemic lupus erythematosus, Blood. juin, vol.31, issue.6, pp.806-818, 1968.

G. I. Ingram, P. J. Kingston, J. Leslie, and E. J. Bowie, Four cases of acquired von Willebrand's syndrome, Br J Haematol. août, vol.21, issue.2, pp.189-99, 1971.

J. Goudemand, B. Samor, C. Caron, B. Jude, D. Gosset et al., Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factorplatelet interaction and response to treatment, Br J Haematol. 1 févr, vol.68, issue.2, pp.227-260, 1988.

A. B. Federici, J. H. Rand, P. Bucciarelli, U. Budde, P. J. Van-genderen et al., Acquired von Willebrand syndrome: data from an international registry, Thromb Haemost. août, vol.84, issue.2, pp.345-354, 2000.

M. Pikta, G. Zemtsovskaja, H. Bautista, G. Nouadje, T. Szanto et al., Preclinical evaluation of a semi-automated and rapid commercial electrophoresis assay for von Willebrand factor multimers, J Clin Lab Anal. 17 févr, 2018.

J. D. Studt, U. Budde, R. Schneppenheim, R. Eisert, M. Von-depka-prondzinski et al., Quantification and Facilitated Comparison of von Willebrand Factor Multimer Patterns by Densitometry, Am J Clin Pathol, vol.116, issue.4, pp.567-74, 2001.

J. L. Blackshear, E. M. Wysokinska, R. E. Safford, C. S. Thomas, M. E. Stark et al., Indexes of von Willebrand Factor as Biomarkers of Aortic Stenosis Severity (from the Biomarkers of Aortic Stenosis Severity [BASS] Study), Am J Cardiol, vol.111, issue.3, pp.374-81, 2013.

W. L. Nichols, M. E. Rick, T. L. Ortel, R. R. Montgomery, J. E. Sadler et al., Clinical and laboratory diagnosis of von Willebrand disease: A synopsis of the 2008 NHLBI/NIH guidelines, Am J Hematol, vol.84, issue.6, pp.366-70, 2009.

U. Budde, R. Schneppenheim, J. Eikenboom, A. Goodeve, K. Will et al., Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD), J Thromb Haemost. 1 mai, vol.6, issue.5, pp.762-71, 2008.

E. Van-belle, A. Rauch, A. Vincentelli, E. Jeanpierre, P. Legendre et al., Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions, Circ Res, vol.116, issue.7, pp.1193-201, 2015.

J. L. Blackshear, C. W. Mcree, and R. E. Safford, Von willebrand factor abnormalities and heyde syndrome in dysfunctional heart valve prostheses, JAMA Cardiol, vol.1, issue.2, pp.198-204, 2016.

L. Ardillon, C. Ternisien, M. Fouassier, M. Sigaud, A. Lefrançois et al., Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'realworld' experience, Haemophilia. 1 sept, vol.21, issue.5, pp.646-52, 2015.

T. Eller, J. Busse, M. Dittrich, T. Flieder, S. Alban et al., rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests, Clin Chem Lab Med CCLM. 1 janv, vol.52, issue.6, 2014.

E. Van-belle, A. Rauch, F. Vincent, R. E. Kibler, M. Labreuche et al., Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement, N Engl J Med, vol.375, issue.4, pp.335-379, 2016.

M. Pidcock and P. Harrison, Can the PFA-100® be modified to detect P2Y12 inhibition?, J Thromb Haemost. 17 mai, vol.4, issue.6, pp.1424-1430, 2006.

J. A. Mourik, . Van, R. Boertjes, I. A. Huisveld, K. Fijnvandraat et al., Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation, Blood. 1 juill, vol.94, issue.1, pp.179-85, 1999.

F. Vincent, A. Rauch, V. Loobuyck, R. E. Nix, C. Vincentelli et al., Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support, J Am Coll Cardiol. 7 mai, vol.71, pp.2106-2124, 2018.

M. Weinstein, J. A. Ware, J. Troll, and E. Salzman, Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate, Blood, vol.71, issue.6, pp.1648-1655, 1988.

A. Veyradier, A. Balian, M. Wolf, G. V. Montembault, S. Obert et al., Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract, Gastroenterology. 1 févr, vol.120, issue.2, pp.346-53, 2001.

T. E. Warkentin, J. C. Moore, S. S. Anand, E. M. Lonn, and D. G. Morgan, Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome, Transfus Med Rev, vol.17, issue.4, pp.272-286, 2003.

F. Pawlitschek, C. Keyl, B. Zieger, U. Budde, F. Beyersdorf et al., Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation, Thromb Haemost, vol.118, issue.01, pp.103-114, 2018.

A. Rauch, C. Caron, F. Vincent, E. Jeanpierre, C. Ternisien et al., A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis, Thromb Haemost. 21 janv, vol.115, issue.5, pp.950-959, 2016.

E. C. Heyde, Gastrointestinal Bleeding in Aortic Stenosis, N Engl J Med. 24 juill, vol.259, issue.4, pp.196-196, 1958.

D. Bourdette and B. Greenberg, Twelve-year history of gastrointestinal bleeding in a patient with calcific aortic stenosis and hemorrhagic telangiectasia, Dig Dis Sci. janv, vol.24, issue.1, pp.77-86, 1979.

J. W. Love, The syndrome of calcific aortic stenosis and gastrointestinal bleeding: resolution following aortic valve replacement, J Thorac Cardiovasc Surg. mai, vol.83, issue.5, pp.779-83, 1982.

J. M. Boyle, H. E. Rowen, H. Saito, W. J. Vicic, and J. L. Ankeney, Severe aortic stenosis in a patient with recurrent gastrointestinal bleeding: replacement of the aortic valve with a porcine xenograft, Am J Gastroenterol. févr, vol.75, issue.2, pp.135-144, 1981.

R. M. King, J. R. Pluth, and E. R. Giuliani, The Association of Unexplained Gastrointestinal Bleeding with Calcific Aortic Stenosis, Ann Thorac Surg, vol.44, issue.5, pp.514-520, 1987.

R. T. Hahn, S. H. Little, M. J. Monaghan, S. K. Kodali, M. Williams et al., Recommendations for Comprehensive Intraprocedural Echocardiographic Imaging During TAVR, JACC Cardiovasc Imaging. mars, vol.8, issue.3, pp.261-87, 2015.

T. E. Warkentin, J. C. Moore, and D. G. Morgan, Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?, Lancet Lond Engl, vol.340, issue.8810, pp.35-42, 1992.

T. E. Warkentin, J. C. Moore, and D. G. Morgan, Gastrointestinal Angiodysplasia and Aortic Stenosis, N Engl J Med. 12 sept, vol.347, issue.11, pp.858-867, 2002.

S. Susen, A. Rauch, E. Van-belle, A. Vincentelli, and P. J. Lenting, Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis, J Thromb Haemost, vol.13, issue.10, pp.1757-67, 2015.

L. W. Miller, F. D. Pagani, S. D. Russell, R. John, A. J. Boyle et al., Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation, N Engl J Med. 30 août, vol.357, issue.9, pp.885-96, 2007.

M. S. Slaughter, J. G. Rogers, C. A. Milano, S. D. Russell, J. V. Conte et al., Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device, N Engl J Med. 3 déc, vol.361, issue.23, pp.2241-51, 2009.

J. K. Kirklin, D. C. Naftel, F. D. Pagani, R. L. Kormos, L. W. Stevenson et al., Sixth INTERMACS annual report: A 10,000-patient database, J Heart Lung Transplant. juin, vol.33, issue.6, pp.555-64, 2014.

F. D. Pagani, L. W. Miller, S. D. Russell, K. D. Aaronson, R. John et al., Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device, J Am Coll Cardiol. 21 juill, vol.54, issue.4, pp.312-333, 2009.

S. Crow, R. John, A. Boyle, S. Shumway, K. Liao et al., Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices, J Thorac Cardiovasc Surg, vol.137, issue.1, pp.208-223, 2009.

S. Crow, C. Milano, L. Joyce, D. Chen, G. Arepally et al., Comparative Analysis of von Willebrand Factor Profiles in Pulsatile and Continuous Left Ventricular Assist Device Recipients, ASAIO J, vol.56, issue.5, pp.441-446, 2010.

N. Uriel, S. Pak, U. P. Jorde, B. Jude, S. Susen et al., Acquired von Willebrand Syndrome After Continuous-Flow Mechanical Device Support Contributes to a High Prevalence of Bleeding During Long-Term Support and at the Time of Transplantation, J Am Coll Cardiol, vol.56, issue.15, pp.1207-1220, 2010.

J. Klovaite, F. Gustafsson, S. A. Mortensen, K. Sander, and L. B. Nielsen, Severely Impaired von Willebrand Factor-Dependent Platelet Aggregation in Patients With a Continuous-Flow Left Ventricular Assist Device (HeartMate II), J Am Coll Cardiol. juin, vol.53, issue.23, pp.2162-2169, 2009.

A. L. Meyer, D. Malehsa, U. Budde, C. Bara, A. Haverich et al., Acquired von Willebrand Syndrome in Patients With a Centrifugal or Axial Continuous Flow Left Ventricular Assist Device, JACC Heart Fail, vol.2, issue.2, pp.141-146, 2014.

M. E. Davis, N. A. Haglund, N. M. Tricarico, M. E. Keebler, and S. Maltais, Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device

, ASAIO J Am Soc Artif Intern Organs, vol.60, issue.3, pp.355-362, 1992.

C. Heilmann, U. Geisen, F. Beyersdorf, L. Nakamura, C. Benk et al., Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS), Intensive Care Med. janv, vol.38, issue.1, pp.62-70, 2012.

C. Heilmann, U. Geisen, F. Beyersdorf, L. Nakamura, G. Trummer et al., Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients, Eur J Cardiothorac Surg. avr, 2011.

F. I. Pareti, A. Lattuada, C. Bressi, M. Zanobini, A. Sala et al., Proteolysis of von Willebrand Factor and Shear Stress-Induced Platelet Aggregation in Patients With Aortic Valve Stenosis, Circulation, vol.102, issue.11, pp.1290-1295, 2000.

A. Vincentelli, S. Susen, L. Tourneau, T. Six, I. Fabre et al., Acquired von Willebrand syndrome in aortic stenosis, N Engl J Med, vol.349, issue.4, pp.343-349, 2003.

T. Spangenberg, U. Budde, D. Schewel, C. Frerker, T. Thielsen et al., Treatment of Acquired von Willebrand Syndrome in Aortic Stenosis With Transcatheter Aortic Valve Replacement, JACC Cardiovasc Interv, vol.8, issue.5, pp.692-700, 2015.

O. Marggraf, S. Schneppenheim, A. Daubmann, U. Budde, M. Seiffert et al., Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation, J Invasive Cardiol. déc, vol.26, issue.12, pp.654-662, 2014.

A. L. Meyer, D. Malehsa, C. Bara, U. Budde, M. S. Slaughter et al., Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device, Circ Heart Fail, vol.3, issue.6, pp.675-81, 2010.

S. Zanardelli, A. Chion, E. Groot, P. J. Lenting, T. Mckinnon et al., A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF, Blood. 24 sept, vol.114, issue.13, pp.2819-2847, 2009.

S. Dassanayaka, M. S. Slaughter, and C. R. Bartoli, Mechanistic Pathway(s) of Acquired Von Willebrand Syndrome with a Continuous-Flow Ventricular Assist Device: In Vitro Findings, ASAIO J, vol.59, issue.2, pp.123-132, 2013.

C. R. Bartoli, S. Dassanayaka, K. R. Brittian, A. Luckett, S. Sithu et al., Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support, J Thorac Cardiovasc Surg. mai, vol.147, issue.5, pp.1634-1677, 2014.

Y. Shoenfeld, M. Eldar, B. Bedazovsky, M. J. Levy, and J. Pinkhas, Aortic stenosis associated with gastrointestinal bleeding. A survey of 612 patients, Am Heart J. août, vol.100, issue.2, pp.179-82, 1980.

G. A. Weaver, H. D. Alpern, J. S. Davis, W. H. Ramsey, and M. Reichelderfer, Gastrointestinal angiodysplasia associated with aortic valve disease: part of a spectrum of angiodysplasia of the gut, Gastroenterology. juill, vol.77, issue.1, pp.1-11, 1979.

M. Kibler, B. Marchandot, N. Messas, J. Labreuche, F. Vincent et al., Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement, J Am Coll Cardiol, vol.72, issue.18, pp.2139-2187, 2018.

J. C. Gill, A. D. Wilson, J. Endres-brooks, and R. R. Montgomery, Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects, Blood, vol.67, issue.3, pp.758-761, 1986.

J. Lahpor, A. Khaghani, R. Hetzer, A. Pavie, I. Friedrich et al., European results with a continuous-flow ventricular assist device for advanced heart-failure patients, Eur J Cardiothorac Surg, 2009.

R. C. Starling, Y. Naka, A. J. Boyle, G. Gonzalez-stawinski, R. John et al., Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation, J Am Coll Cardiol, vol.57, pp.1890-1898, 2011.

T. Hasin, Y. Marmor, W. Kremers, Y. Topilsky, C. J. Severson et al., Readmissions after implantation of axial flow left ventricular assist device, J Am Coll Cardiol. 15 janv, vol.61, issue.2, pp.153-63, 2013.

C. T. Holley, L. Harvey, S. S. Roy, R. Cogswell, P. Eckman et al., Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation, ASAIO J Am Soc Artif Intern Organs, vol.61, issue.6, pp.635-644, 1992.

A. Guha, C. L. Eshelbrenner, D. M. Richards, and H. P. Monsour, Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management, Methodist DeBakey Cardiovasc J. mars, vol.11, issue.1, pp.24-31, 2015.

M. C. Bunte, E. H. Blackstone, L. Thuita, J. Fowler, L. Joseph et al., Major Bleeding During HeartMate II Support, J Am Coll Cardiol. 10 déc, vol.62, issue.23, pp.2188-96, 2013.

N. Uriel, P. C. Colombo, J. C. Cleveland, J. W. Long, C. Salerno et al., Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months, Circulation, vol.135, issue.21, pp.2003-2012, 2017.

J. Kang, S. Hennessy-strahs, P. Kwiatkowski, C. A. Bermudez, M. A. Acker et al., Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia, Circ Res, vol.121, issue.8, pp.963-972, 2017.

C. R. Bartoli, D. M. Zhang, S. Hennessy-strahs, J. Kang, D. J. Restle et al., Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis, Circ Heart Fail. sept, vol.11, issue.9, p.4638, 2018.

O. Wever-pinzon, C. H. Selzman, S. G. Drakos, A. Saidi, G. J. Stoddard et al., Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the ContinuousFlow Left Ventricular Assist Device HeartMate II, Circ Heart Fail, vol.6, issue.3, pp.517-543, 2013.

J. L. Blackshear, E. M. Wysokinska, R. E. Safford, C. S. Thomas, B. P. Shapiro et al., Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation, J Thromb Haemost, vol.12, issue.12, pp.1966-74, 2014.

Y. Xiong, Z. Hu, X. Han, B. Jiang, R. Zhang et al., Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways, Cell Res. juin, vol.23, issue.6, pp.820-854, 2013.

R. R. Baliga, From clinical observation to mechanism--Heyde's syndrome, N Engl J Med, vol.368, issue.6, p.579, 2013.

V. Auffret, T. Lefevre, E. Van-belle, H. Eltchaninoff, B. Iung et al., Temporal Trends in Transcatheter Aortic Valve Replacement in France, J Am Coll Cardiol, vol.70, issue.1, pp.42-55, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01744757

F. Vincent, A. Rauch, V. Loobuyck, M. Moussa, F. Juthier et al., Willebrand Factor for Aortic Valve Intervention: From Bench to Real-Time Bedside Assessment, Circ Res. 25 mai, vol.122, issue.11, pp.1499-500, 2018.

F. Vincent, A. Rauch, H. Spillemaeker, A. Vincentelli, C. Paris et al., Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of MiniInvasive Transcatheter Aortic Valve Replacement?, JACC Cardiovasc Interv. 3 sept, vol.11, issue.17, pp.1775-1783, 2018.

P. Pibarot, R. T. Hahn, N. J. Weissman, M. Arsenault, J. Beaudoin et al., Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve, JAMA Cardiol, vol.2, issue.11, pp.1208-1224, 2017.

E. Van-belle, F. Juthier, S. Susen, A. Vincentelli, B. Iung et al.,

, Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures Analysis of Predictors and Impact on Long-Term Mortality: Insights From the FRANCE2 Registry, vol.129, pp.1415-1442, 2014.

H. B. Ribeiro, F. L. Ven, É. Larose, A. Dahou, L. Nombela-franco et al., Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation, Heart, vol.100, issue.24, pp.1924-1956, 2014.

M. Kibler, B. Marchandot, N. Messas, C. T. Vincent, F. Hunolstein et al., CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement, Thromb Haemost, 2018.

, ANNEXES Annexe 1 : facteur Willebrand et évaluation en temps-réel des procédures valvulaires aortiques : « from bench to bedside

F. Vincent, A. Rauch, V. Loobuyck, M. Moussa, F. Juthier et al., von Willebrand Factor for Aortic Valve Intervention: From Bench to RealTime Bedside Assessment, Circulation Research, vol.122, pp.1499-1500, 2018.

, Annexe 2 : le monitoring du facteur Willebrand en salle de cathétérisme : la ceinture de sécurité du TAVI mini-invasif ? (review)

F. Vincent, A. Rauch, H. Spillemaeker, A. Vincentelli, C. Paris et al., Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?, JACC: Cardiovascular Interventions, vol.11, pp.1775-1778, 2018.

, Annexe 3 : Von Willebrand Factor and management of Heart Valve Disease : Ready for Primetime ? (review)

E. Van-belle, *. Md, and P. ,

F. Vincent and *. Md;,

A. Rauch, *. Md, and P. ,

C. Casari, P. Phd;-emmanuelle-jeanpierre, M. Loobuyck, M. Delhaye, M. Spillemaeker et al.,

A. Vincentelli, A. Md;-phd, . Dupont, . Md, P. J. Phd et al., PhD*

S. Susen and *. Md, PhD 2ème soumission en cours de reviewing par Journal of american college of cardiology *: These authors contributed equally to the manuscript